News about Ingredients

Panacea Biotec supplies maiden shipment of Sputnik V's second component produced in India

Panacea Biotec supplies maiden shipment of Sputnik V's second component produced in India

The Russian Direct Investment Fund (RDIF) and Panacea Biotec have announced the supply of the first shipment out of one million doses of the second component (human adenovirus serotype 5) of the Russian Sputnik V coronavirus vaccine manufactured by Panacea Biotec for sale in India, the company said in a statement

Ingredients | 08/09/2021 | By Darshana

AffaMed inks agreement with Beijing Tiantan Hospital & IBT to promote & develop digital therapy in neurological diseases

AffaMed inks agreement with Beijing Tiantan Hospital & IBT to promote & develop digital therapy in neurological diseases

AffaMed Therapeutics, a global clinical stage biopharmaceutical company, announced during the recent "China International Trade in Services Fair 2021" a strategic cooperation partnership with Beijing Tiantan Hospital of Capital Medical University and Beijing Infinite Brain Technologies (IBT)

Ingredients | 07/09/2021 | By Darshana

Pharma technology vocational course introduced by Telangana not approved by PCI

Pharma technology vocational course introduced by Telangana not approved by PCI

The new pharma technology vocational course introduced by the Board of Intermediate (BIE) of Telangana state is expected to face tough hurdles for the students as the BIE has not taken any kind of approval from the Pharmacy Council of India (PCI)

Ingredients | 01/09/2021 | By Darshana

WHO guidelines include Roche?s cobas MTB & cobas MTB-RIF/INH tests for use on cobas 6800/8800 Systems to detect TB and drug-resistant TB

WHO guidelines include Roche?s cobas MTB & cobas MTB-RIF/INH tests for use on cobas 6800/8800 Systems to detect TB and drug-resistant TB

Roche announced that the cobas MTB and cobas MTB-RIF/INH tests for use on the cobas 6800/8800 Systems are included as part of the updated World Health Organization (WHO) policy guidelines on nucleic acid amplification tests (NAATs) to detect tuberculosis (TB) and drug-resistant TB

Ingredients | 10/07/2021 | By Darshana

DoP re-invites applications to manufacture erythromycin thiocyanate under PLI scheme

DoP re-invites applications to manufacture erythromycin thiocyanate under PLI scheme

The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under the production linked incentive (PLI) scheme for promotion of domestic manufacturing of 41 KSMs/DIs/APIs

Ingredients | 07/07/2021 | By Darshana

Centrient Pharmaceuticals boosting statins API manufacturing capacity

Centrient Pharmaceuticals boosting statins API manufacturing capacity

Centrient Pharmaceuticals today announced to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed. The company will double its statins production capacity that will enable it to meet the growing demand for its sustainably manufactured Atorvastatin

Ingredients | 24/06/2021 | By Darshana

Glenmark Pharma releases interim data from PMS study on favipiravir

Glenmark Pharma releases interim data from PMS study on favipiravir

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced interim data of 503 patients from its post marketing surveillance (PMS) study on favipiravir in India. The PMS study commenced in July 2020 aimed to evaluate safety and efficacy of favipiravir in mild to moderate Covid-19 patients

Ingredients | 09/06/2021 | By Darshana

Biogen, Ginkgo Bioworks enter agreement to develop novel gene therapy manufacturing platform

Biogen, Ginkgo Bioworks enter agreement to develop novel gene therapy manufacturing platform

Biogen and Ginkgo Bioworks announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors

Ingredients | 24/05/2021 | By Darshana

Cipla ready to launch COVID-19 treatment drug favipiravir

Cipla ready to launch COVID-19 treatment drug favipiravir

Cipla is set to launch coronavirus COVID-19 treatment drug favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process

Ingredients | 24/07/2020 | By Darshana 172

FDA Continues to Accelerate Development of Novel Therapies for COVID-19

FDA Continues to Accelerate Development of Novel Therapies for COVID-19

As part of the Trump Administration?s all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments

Ingredients | 01/04/2020 | By Darshana 233


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology